Patent Assignment
Reel/Frame 047761/0435
Assignment of Assignor's Interest
Recorded: 2018-12-10
Pages: 42
Assignor
ASTRAZENECA AB
Executed: 2018-12-04
Assignee
COVIS PHARMA B.V.
OUDE UTRECHTSEWEG 32, 3743 KN, BAARN, NETHERLANDS
Covered Properties
(26)
Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa
Patent:
6,767,901 →
Application:
10/110,629 →
Ciclesonide Containing Aqueous Pharmaceutical Composition
Patent:
8,383,611 →
Application:
10/110,632 →
Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation
Ciclesonide-Containing Sterile Aqueous Suspension
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Combination Medicament
Process for preparing crystalline ciclesonide with defined particle size
Formoterol and Ciclesonide Combination
Use of Ciclesonide for the Treatment of Respiratory Diseases
Compliance monitor and method
Stabilized Pharmaceutical Product
Stable Pharmaceutical Products
Use of Ciclesonide for the Treatment of Respiratory Diseases in a Smoking Patient
Application:
11/578,294 →
Publication:
US 2007/0134165
Ciclesonide containing sterile aqueous suspension
Ciclesonide-Containing Sterile Aqueous Suspension
Stabilized Pharmaceutical Product
Stable Pharmaceutical Products
Combination Medicament
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Stabilized Pharmaceutical Product
Stabilized Pharmaceutical Product
Ciclesonide Containing Aqueous Pharmaceutical Composition
Application:
13/688,659 →
Publication:
US 2013/0095146
Use of Ciclesonide for the Treatment of Respiratory Diseases
Application:
13/744,962 →
Publication:
US 2013/0143849
Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation
Aqueous Suspensions of Ciclesonide for Nebulisation
Metered Dose Inhaler
Patent:
582,544 →
Application:
29/283,277 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019781/0225 →
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Change of Name
Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0224 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0478 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0179 →
Merger
Feb 15, 2016
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 037820/0324 →
Merger
Feb 15, 2016
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 037820/0360 →
Change of Name
Feb 15, 2016
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 038020/0258 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
Notice of Grant of Security Interest in Intellectual Property (Second Lien)
Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
Release of Security Interest
Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
Release of Security Interest in Patents
Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →
Confirmatory Grant of Security Interest in United States Patents
May 27, 2025
From: COVIS PHARMA GBMH
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 071409/0368 →